PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE I GRANT

shash683
Nov 10, 2019
1 min read

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards will aid with continued technical and business development of their novel device.

Recent Posts

See All

PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE II GRANT

PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.

PNEUMONIX MEDICAL ENDORSED BY JOHNS HOPKINS LUNG CANCER SCREENING INITIATIVE

PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...

PNEUMONIX SELECTED TO PRESENT AT 2019 ANGEL CAPITAL ASSOCIATION INNOVATION SHOWCASE

PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most...

Comments